<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36003052</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1399-3038</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</Title><ISOAbbreviation>Pediatr Allergy Immunol</ISOAbbreviation></Journal><ArticleTitle>Severe vaccine-acquired rotavirus infection in an infant with primary intestinal lymphangiectasia.</ArticleTitle><Pagination><StartPage>e13834</StartPage><MedlinePgn>e13834</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pai.13834</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cabrerizo</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Enterovirus and Viral Gastroenteritis Unit, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hidalgo-Montes</LastName><ForeName>Inmaculada</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pediatric Gastroenterology, University Hospital La Paz, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendez-Echevarria</LastName><ForeName>Ana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7455-9080</Identifier><AffiliationInfo><Affiliation>Pediatric Infectious and Tropical Diseases Department, La Paz University Hospital, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Research Network in Pediatric Infectious Diseases (RITIP), Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBERINFEC (CB21/13/00049), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrieguez-Pena</LastName><ForeName>Rebeca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Immunology Department, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz-Carrascoso</LastName><ForeName>Guillermo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Hospital Universitario La Paz, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez-Ojinaga</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pediatric Gastroenterology, University Hospital La Paz, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Rosal</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Pediatric Infectious and Tropical Diseases Department, La Paz University Hospital, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Research Network in Pediatric Infectious Diseases (RITIP), Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pastrian</LastName><ForeName>Laura G</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Department of Pathology, Hospital Universitario La Paz, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandez-Garcia</LastName><ForeName>Maria Dolores</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Enterovirus and Viral Gastroenteritis Unit, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pediatr Allergy Immunol</MedlineTA><NlmUniqueID>9106718</NlmUniqueID><ISSNLinking>0905-6157</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022243">Rotavirus Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014612">Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012401" MajorTopicYN="Y">Rotavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012400" MajorTopicYN="Y">Rotavirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022243" MajorTopicYN="Y">Rotavirus Vaccines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014612" MajorTopicYN="Y">Vaccines</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">attenuated vaccine</Keyword><Keyword MajorTopicYN="N">intestinal lymphangiectasis</Keyword><Keyword MajorTopicYN="N">rotavirus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>25</Day><Hour>2</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36003052</ArticleId><ArticleId IdType="doi">10.1111/pai.13834</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>European Medicine Agency. Rotarix summary of product characteristics. https://www.ema.europa.eu/documents/product-information/rotarix-epar-product-information_en.pdf.</Citation></Reference><Reference><Citation>Bakare N, Menschik D, Tiernan R, Hua W, Martin D. Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the vaccine adverse events reporting system (VAERS). Vaccine. 2010;28:6609-6612.</Citation></Reference><Reference><Citation>Lopez RN, Day AS. Primary intestinal lymphangiectasia in children: a review. J Paediatr Child Health. 2020;56:1719-1723.</Citation></Reference><Reference><Citation>Lee SJ, Song HJ, Boo SJ, Na SY, Kim HU, Hyun CL. Primary intestinal lymphangiectasia with generalized warts. World J Gastroenterol. 2015;21:8467-8472.</Citation></Reference><Reference><Citation>Prasad D, Srivastava A, Tambe A, Yachha SK, Sen SM, Poddar U. Clinical profile, response to therapy, and outcome of children with primary intestinal lymphangiectasia. Dig Dis. 2019;37:458-466.</Citation></Reference><Reference><Citation>Dierselhuis MP, Boelens JJ, Versteegh FGA, Weemaes C, Wulffraat NM. Recurrent and opportunistic infections in children with primary intestinal lymphangiectasia. J Pediatr Gastroenterol Nutr. 2007;44:382-385.</Citation></Reference><Reference><Citation>Kaneko M, Takanashi S, Thongprachum A, et al. Identification of vaccine-derived rotavirus strains in children with acute gastroenteritis in Japan, 2012-2015. PLoS ONE. 2017;12(9):e0184067.</Citation></Reference><Reference><Citation>Hungerford D, Allen DJ, Nawaz S, et al. Impact of rotavirus vaccination on rotavirus genotype distribution and diversity in England, September 2006 to august 2016. Euro Surveill. 2019;24(6):1700774.</Citation></Reference><Reference><Citation>Anderson EJ. Rotavirus vaccines: viral shedding and risk of transmission. Lancet Infect Dis. 2008;8:642-649.</Citation></Reference><Reference><Citation>Gower CM, Dunning J, Nawaz S, Allen D, Ramsay ME, Ladhani S. Vaccine-derived rotavirus strains in infants in England. Arch Dis Child. 2020;105:553-557.</Citation></Reference><Reference><Citation>Tanita K, Kawamura Y, Miura H, et al. Case report: rotavirus vaccination and severe combined immunodeficiency in Japan. Front Immunol. 2022;13. doi:10.3389/fimmu.2022.786375</Citation></Reference><Reference><Citation>Rossignol JF, Abu-Zekry M, Hussein A, Santoro MG. Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial. Lancet. 2006;368:124-129.</Citation></Reference><Reference><Citation>Zeller M, Patton JT, Heylen E, et al. Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in rotarix and RotaTeq. J Clin Microbiol. 2012;50:966-976.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>